SKELETAL MUSCLES adjust their contractile output over an exceptionally wide dynamic range, as needed to produce movements ranging from sitting and standing, to athletics and dance. At the single fiber level, the force generated by skeletal muscles is determined, ultimately, by the formation of cycling cross bridges between actin and myosin. This interaction requires Ca 2ϩ and is governed by the simple relationship: force is proportional to intracellular ionized Ca 2ϩ . Cross-bridge formation is inhibited in resting muscle when Ca 2ϩ is sequestered within the sarcoplasmic reticulum (SR); it is activated when stored Ca 2ϩ is released into the cytosol, allowing actin-myosin interactions to proceed. Contraction stops as Ca 2ϩ is actively resequestered by the Ca 2ϩ -ATPase of the SR (SERCA1). Thus Ca 2ϩ is the central messenger in muscle activation, and the amplitude and time course of the intracellular Ca 2ϩ change is the major determinant of contractile output.
The key mechanisms that activate Ca 2ϩ release from the SR are now well defined. This sequence, termed excitation-contraction coupling, begins when an excitatory input from the motor nerve triggers a propagating action potential on the muscle membrane. The action potential rapidly depolarizes the entire sarcolemma, including transverse tubules, which invaginate from the surface membrane and form specialized junctions (triads) with the SR along much of their length. The triad junction serves as a platform for assembling sarcolemmal calcium channels (dihydropyridine receptors, DHPRs), SR Ca 2ϩ release channels (ryanodine receptors, RyR1), and additional proteins into a macromolecular complex that spans the junctional gap and controls Ca 2ϩ release (Fig. 1) . Voltage-sensing domains of the DHPR move in response to membrane depolarization and, through concerted molecular interactions between cytoplasmic regions of the DHPR and the RYR1, cause the RyR1 to open. In this way, the opening of an integral SR membrane calcium channel is gated by conformational transitions of a sarcolemmal, voltage-dependent calcium channel. Consequently, Ca 2ϩ release in skeletal muscle remains under control of the plasma membrane potential.
The entire process, from membrane excitation to RyR1 opening, is complete in milliseconds. Overall, it operates largely as an on/off switch, ensuring that Ca 2ϩ release occurs rapidly and synchronously in response to each excitatory input from the motor nerve. In contrast, the Ca 2ϩ output that results from RyR1 opening is a more highly regulated process. SR Ca 2ϩ release flux involves the coordinated opening of multiple RyR1s and can be modulated at many levels. These include the sensitivity of RyR1s to gating by the DHPR, the interactions between DHPR-coupled and noncoupled RyR1s, inactivation of RyR1s by Ca The Ca 2ϩ binding protein S100A1 has received particular attention as a potential Ca 2ϩ -dependent regulator of ryanodine receptor activity in striated muscles (6, 10, 16) . S100A1 is a member of the S100 family of Ca 2ϩ binding proteins containing two EF-hand calcium-binding motifs and is the most abundant S100 protein in skeletal muscle (reviewed in Ref. 12) . S100 proteins such as calmodulin (CaM) commonly function as Ca 2ϩ sensors that, upon Ca 2ϩ binding, assume a conformation that is able to interact with target proteins to elicit varied biological responses. Fig. 1 . Ca 2ϩ release in skeletal muscle is initiated by voltage-driven interactions between the ryanodine receptor RyR1 and the dihydropyridine receptor DHPR. RyR1s associate with each other on the SR surface of the triad junction, with every alternate RyR1 coupled to a cluster of four DHPRs (tetrads) in the transverse tubule membrane. Each DHPR in a tetrad interacts with one of the four subunits of RyR1. This schematic (left) depicts a cross-sectional plane through two subunits of a coupled RyR1 (left) interacting with two DHPRs. Voltage-driven movements of the DHPR initiate molecular interactions between cytosolic regions of DHPRs (II-III loop) and a coupled RyR1, leading to RyR1 channel opening. This initiating event activates noncoupled RyR1s, possibly via coordinated interactions between adjacent RyR1s or a secondary Ca 2ϩ -induced, Ca 2ϩ -release, to effect a rapid efflux of Ca 2ϩ from the SR. S100A1 binds specifically to a CaM binding site on RyR1 and enhances the Ca 2ϩ release flux resulting from this coordinated opening of multiple RyR1s. The CaM/S100A1 site is present on a cytosolic domain of each of the four subunits of RyR1 near regions of intersubunit contacts. The complete functional complex of RyR1 also includes the FKBP subunit, calsequestrin, triadin, junction, and other ancillary proteins (not shown) having regulatory or structural functions.
Studies early on suggested that S100A1 may play a role in Ca 2ϩ cycling (reviewed in Ref. 15 ). S100A1 associates with purified skeletal muscle SR membranes to alter Ca 2ϩ release (2, 3). It binds specifically to the purified RyR1 in a Ca 2ϩ -dependent manner, at regions overlapping with CaM binding sites, and enhances the open probability of RyR1 reconstituted in lipid bilayers (13) . Subsequent studies demonstrated that recombinant S100A1 applied to intact, permeabilized muscle fibers enhances Ca 2ϩ release and contractile force evoked by 5 mM caffeine, without change in SR Ca 2ϩ load or reuptake (7). The enhancement required specific regions of S100A1 that participate in conformational changes induced by Ca 2ϩ binding. These findings supported the idea that S100A1 enhances muscle contractility by enhancing a Ca 2ϩ -dependent step in excitation-contraction coupling at the level of SR Ca 2ϩ release. However, they left unresolved the question of whether this enhancement plays a physiological role in voltage-gated Ca 2ϩ release. Caffeine can induce contraction in permeabilized muscle fibers in the absence of membrane excitation, by potentiating a slower, Ca 2ϩ -induced mechanism of RyR1 opening. Structural studies further identified a specific interaction site on RyR1 that associates with S100A1 (10). The site corresponds to a CaM binding region that is conserved between RyR1 and RyR2 and has been shown to modulate RyR channel activation (5, 11, 14) and intersubunit interactions (18) . S100A1 competes with CaM for this site, binding with micromolar affinity in a Ca 2ϩ -dependent manner (10, 16) . Notably, this site is contained within the large cytosolic domain of RyR1 that spans the triad junction. This location makes it well-suited to respond to the immediate Ca 2ϩ flux that results from DHPR-initiated RyR1 opening.
Collectively, these findings obtained from purified membranes, isolated ryanodine receptors, and permeabilized skeletal muscle fibers established that S100A1 is capable of specific molecular interactions with RyR1 leading to altered function, and that it is able to modulate both Ca 2ϩ release and contractile force at physiologically relevant concentrations. Two key gaps in the understanding of the role of S100A1 in skeletal muscle remained: 1) Does this regulation operate under physiological conditions of voltage-dependent gating of RyR1 by the DHPR? 2) Is RyR1 the molecular target of S100A1 actions in vivo?
A recent series of studies (8 -10, 16 ) addresses these fundamental questions by measuring membrane excitation, gating charge movements of the DHPR, Ca 2ϩ release, and contractile force in intact skeletal muscles of wild-type (WT) and S100A1 knock-out mice (KO). The absence of S100A1 significantly attenuates both the cytosolic Ca 2ϩ change and the rising rate of Ca 2ϩ release elicited by action potential stimulation, without change in resting Ca 2ϩ levels or SR calcium load. Viral delivery of S100A1 is able to rescue this phenotype and restore normal Ca 2ϩ release (10) . Detailed comparisons of DHPR expression, DHPR Ca 2ϩ currents, and charge movement in WT and KO muscle further established that the effects of S100A1 on Ca 2ϩ release flux do not involve the DHPR (8, 9) . Rather, the reduced Ca 2ϩ release flux in KO skeletal muscle attenuates a secondary component of charge movement Q␥. Voltagedriven transitions of the DHPR leading to RyR1 opening, reflected in the primary Q␤ charge movement, are not altered in KO muscle. This finding also resolved a long-standing discussion in the field regarding the origin of Q␥. The absence of Q␥ in KO fibers with reduced Ca 2ϩ release flux supports the idea that Q␥ is a consequence and not a cause of Ca 2ϩ release. These studies firmly established that S100A1 enhances electrically evoked Ca 2ϩ release in intact muscle fibers, under control of the DHPR and the sarcolemmal membrane potential. They strongly supported the idea that S100A1 exerts its effects through specific interactions with RyR1.
In this issue of American Journal of Physiology-Cell Physiology, Prosser et al (7a) present an integrated picture of the physiological actions of S100A1 in skeletal muscle from the propagating action potential to contractile force elicited by nerve stimulation in vivo. The action potential waveform measured with a voltage-sensitive dye is unchanged in muscle fibers from KO mice. This finding directly establishes that S100A1 does not alter early events in membrane excitation. When KO muscle fibers are stimulated with repetitive trains of action potentials, a pattern that mimics the natural input from the motor nerve, both the Ca 2ϩ release flux and the cytosolic Ca 2ϩ change are depressed. Moreover, this depression increases with the duration of stimulation, indicating that KO fibers have a reduced capacity to maintain Ca 2ϩ release during sustained muscle activity. Inactivation of release flux, a Ca 2ϩ -dependent process that follows RyR1 opening, is also enhanced. These alterations in Ca 2ϩ release flux, a measure of RyR1 activity in intact muscle, strongly support the idea that RyR1 is the molecular target of S100A1 in vivo. Importantly, S100A1 KO muscle fibers produce lower isometric force in response to both twitch and tetanic stimulation, as expected from the reduced Ca 2ϩ release flux and myoplasmic Ca 2ϩ transient. S100A1 KO muscle fibers also fatigue more rapidly during repetitive stimulation, suggesting that the enhancement of SR Ca 2ϩ release by S100A1 plays a physiological role in protecting WT muscle from fatigue during sustained activity. Together, these findings put the focus squarely on RyR1 as the molecular target of the physiological actions of S100A1 in intact skeletal muscle. They provide compelling evidence that S100A1 is a specific modulator of RyR1-mediated Ca 2ϩ release in skeletal muscle, under physiological conditions of membrane excitation and contraction.
Together, the results of this and previous studies present an emerging picture of the mechanism by which S100A1 modulates contractility in skeletal muscle. They suggest that S100A1 acts directly on RyR1 to enhance RyR1 activation. S100A1 does not directly open the RyR1, but it enhances the Ca More broadly, these current and earlier findings will direct future questions concerning the regulation of RyR1 activity by S100A1. Presumably, as with other S100 proteins, Ca 2ϩ binding initiates a conformational changes on S100A1 that enhances its interaction with RyR1. It will be important for future studies to determine the consequence of S100A1 binding on RyR1 conformation and the mechanism by which this presumed conformational change enhances RyR1 activity. For example, does S100A1 modulate coupled or uncoupled RyR1s, or both? And, does it signal to additional downstream targets in skeletal muscle, such as mitochondria or contractile elements, as it does in the heart?
